SCHEMBL26501351

SCHEMBL26501351

CC(C)OCC1(CN(C)C(=O)CC(C)(C)CC(=O)C(C)(C)C)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26511520 0.73 — —
SCHEMBL24730839 0.67 OPRM1 (0.31) —
SCHEMBL26500961 0.65 — —
SCHEMBL23424122 0.62 HMGCR (0.36) —
SCHEMBL13323634 0.61 CYP1A2 (0.38) —
SCHEMBL26501383 0.61 EPHX1 (0.32) —
SCHEMBL26501291 0.60 — —
SCHEMBL22967780 0.60 SLC6A3 (0.33) —
SCHEMBL25481636 0.59 NUDT1 (0.33) —
SCHEMBL14134634 0.59 MAPK1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230321253-A1 BIFUNCTIONAL COMPOUNDS AND PHARMACEUTICAL USES THEREOF Risen (Suzhou) Pharma Tech Co., Ltd. (CN) 2023-10-12 — — US disclosed
Send feedback